Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023
Full-Year Revenue Surges by 60% with Significant Advances in Dermatological and Gastroenterological Diagnostics
Source: yahoo.com
Stay updated with breaking news from Bioscience President. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Full-Year Revenue Surges by 60% with Significant Advances in Dermatological and Gastroenterological Diagnostics
Shares of Pacific Biosciences of California traded to a new 52-week high after the firm reported that a Softbank Group subsidiary will invest $900 million to support its growth initiatives.